Merck's combination of a wide lineup of high-margin drugs and a pipeline of new drugs should ensure strong returns on invested capital over the long term. Further, following the divestment of the ...
4d
News Letter on MSNBelfast business hub appoints former Matrix chair to senior innovative roleNorthern Ireland science and Technology hub, Catalyst has announced the appointment of Dr Rob Grundy as its new director of ...
This is the new norm within the world of medicine, and Merck navigates it nicely even if not explosively. Better still, with the stock now down 25% from June's peak, newcomers will be stepping in at a ...
For instance, its current top-selling cancer drug, Keytruda, was actually the prize from 2009's acquisition of Schering-Plough. And, now that the end of Keytruda's smashing commercial success is ...
The European Laboratory Research & Innovation Group (ELRIG), a not-for-profit, volunteer-led organisation for the drug discovery community, today announced the keynote speakers for Research & ...
Ideology isn’t everything.” Fred Hassan, the former chief executive of Schering-Plough who now advises private equity group Warburg Pincus, said: “There’s a lot of good science that got ...
Two side-by-side condominiums on the ninth floor of the Palm Beach Biltmore have sold together for $14 million, the price recorded Jan. 14 with the deed. The apartments — Unit Nos. 905 and 906 ...
The European Laboratory Research & Innovation Group (ELRIG) has announced the keynote speakers for Research & Innovation 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results